Laser and cisplatinum for treatment of human squamous cell carcinoma

Laryngoscope

Volumn 108, Issue 9, 1998, Pages 1269-1276

  Paiva, Marcos B ^a   Graeber, Ines P ^b   Castro, Dan J ^a   Suh, Michael J ^d   Paek, Woo H ^a   Eshraghi, A Amir ^c   Saxton, Romaine E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; INTRATUMORAL DRUG ADMINISTRATION; LASER COAGULATION; MALE; MOUSE; NEODYMIUM LASER; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LASER SURGERY; MALE; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL;

EID: 0031717121     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199809000-00002     Document Type: Article

References (44)

1. Clark JR, Fallon BG, Frei III F. Induction chemotherapy: An initial treatment for advanced head and neck cancer. A model for the multidisciplinary treatment of solid tumors. In: De Vita Jr, VT, Hellman S, Rosenberg, (eds.) Important Advances in Oncology. Philadelphia, PA: JB Lippincott Co.; 1987:175-95.
2. Vokes EE, Weichselbaum RR, Lippman JM, Hong WK. Head and neck cancer: review article. N Engl J Med 1993; 328:184-194.
3. Saxton RE, Paiva MB, Lufkin RB, Castro DJ. Laser photochemotherapy: A less invasive approach for treatment of cancer. Semin Surg Oncol 1995;11:283-9.
4. Glicksman AS, Slotman G, Doolittle C III, et al. Concurrent cis-platinum and radiation with or without surgery for advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1994;30(5):1043-50.
5. Guillot T, Spielmann M, Kac J, et al. Neoadjuvant chemotherapy in multiple synchronous head and neck and esophagus squamous cell carcinomas. Laryngoscope 1992;102(3):311-9.
6. Loehrer PJ, Einhorn LH. Cisplatin. Ann Intern Med 1984;100:704-13.
7. Merlano M, Esposito M, Fulco RA, Benasso M, Russo R. Topical administration of cisplatin in far-advanced SCCA of the head and neck. Eur J Cancer Clin Oncol 1986;22:119-20.
8. Jain RK. Barriers to drug delivery in solid tumors. Scientific American 1994;27(1):58-65.
9. Deurloo MJM, Kop W, VanTellingen O, Batelink H, Begg AC. Intratumoral administration of cisplatin in slow-release devices, part II. Pharmacokinetics and intratumoral distribution. Cancer Chemother Pharmacol 1991;27:347-53.
10. Nagase M, Nomura T, Nakajima T. Effects of intralesional versus Ip administration of Cisplatin on squamous cell carcinoma of mice. Cancer Treat Reports 1987;71(9):825-9.
11. Krag DN, Theon AP, Schneider PO, Goodnight JE. Intralesional cisdiamminedichloroplatinum and purified collagen treatment of human metastatic malignancies: A feasibility study. J Surg Oncol 1990;43:83-7.
12. Burris HA, Vogel CL, Castro DJ, et al. Intratumoral cis-platin/epinephrine injectable gel as a palliative treatment for accessible solid tumors: A multicenter pilot study. Otolaryngol Head Neck Surg 1998;118(4):496-503.
13. Theon AP, Madewell BR, Moore AS, Stephens C, Krag DN. Localized thermo-cisplatin therapy: A pilot study in spontaneous canine and feline tumours. Int J Hyperthermia 1991;7:881-92.
14. Hahn GM. Potential for therapy of drugs and hyperthermia. Cancer Res 1979;39:2264-8.
15. Amichetti M, Graiff C, Fellin G, et al. Cisplatin, hyperthermia, and radiation (trimodal therapy) in patients with locally advanced head and neck tumors: A phase I-II study. Int J Radiat Oncol Biol Phys 1993;23:801-7.
16. Paiva MB, Saxton RE, Letts GA, et al. Interstitial laser photochemotherapy with new anthrapyrazole drugs for the treatment of xenograft tumors. J Clin Med Surg 1995;13:307-13.
17. Paiva MB, Saxton RE, VanderWerf QM, et al. Cisplatinum and interstitial laser therapy for advanced head and neck cancer: A preclinical study. Laser Surg Med 1997;21(5):423-31.
18. Graeber IP, Paiva MB, Eshraghi AA, Suh M, Castro DJ, Saxton RE. Anthrapyrazoles and interstitial laser photochemotherapy for experimental treatment of squamous cell carcinoma. Laryngoscope 1998, in press.
19. Miller RC, Richard M, Baird C, Martin S, Hall EJ. Interaction of hyperthermia and chemotherapy agents: Cell lethality and oncogenic potential. Int J Hyperthermia 1994;10:89-99.
20. Engin K. Biological rationale and clinical experience with hyperthermia. Contr Clin Trials 1996;17:316-42.
21. Fisher GA, Hahn GM. Enhancement of cisplatinum (II) diamminechloride cytotoxicity by hyperthermia. Nat Cancer Inst Mongr 1982;61:255-7.
22. Hettinga JVE, Lemstra W, DeVries EGE, Konings AWT, Kampinga HH. Sensitization to cisplatin action by stepdown heating in CDDP-sensitive and -resistant cells. Int J Cancer 1995;61:722-6.
23. Herman TS, Teicher BA. Summary of studies adding systemic chemotherapy to local hyperthermia and radiation. Int J Hyperthermia 1994;4:143-158.
24. Los G, Tuyt L, VanVugt MJH, Schornagel J, Pinedo HM. Effect of temperature on the interaction of cisplatin and carboplatin with cellular DNA. Biochem Pharmacol 1993;46:1229-37.
25. Castro DJ, Calcaterra T, Saxton RE, et al. Ultrasound-guided minimally invasive therapy for recurrent head and neck carcinomas. Operative Techn Otol Head Neck Surg 1994;4:259-66.
26. Joffee SN, Tajiri H, Oguro Y, Daikunozo N, Suzuki S. Laserthermia: A new method of interstitial local hyperthermia using the contact Nd:YAG laser. Radiol Clin North Am 1989;27:611-20.
27. Davidson BS, Izzo F, Cromeens DM, Stephens LC, Siddik ZH, Curley SA. Collagen matrix cisplatin prevents local tumor growth after margin-positive resection. J Surg Res 1995;58:618-24.
28. Theon AP, Pascoe JR, Meagher DM. Perioperative intratumoral administration of cisplatin for treatment of cutaneous tumors in equidae. J Am Vet Med Assoc 1994; 205(8):1170-6.
29. Yu N, Conley F, Luck EE, Brown DM. Response of mouse tumors to matrix-associated cisplatin intratumoral implants. Monogr Natl Cancer Inst 1988;6:137-40.
30. 195m Pt-Cisplatinum in murine tumors with a novel injectable sustained-release drug delivery system. Proc Am Assoc Cancer Res 1995;36:310.
31. Sakurai K, Yoshiga K, Tsumura M, Takada K Effects of thermochemotherapy [1-Hyexylcarbamoyl-5-fluorouracil (HCFU) combined with hyperthermia]: a basic study on the most effective timing and sequence in vivo. Anticancer Res 1996;16:2789-2734.
32. Kitamura K, Kuwano H, Matsuda H, Toh Y, Masuda H, Sugimachi K. Synergistic effects of intratumor administration of cis-diamminedichloroplatinum (II) combined with local hyperthermia in melanoma bearing mice. J Surg Oncol 1992;51:188-94.
33. Song CW. Effect of local hyperthermia on blood flow and microenvironment: A review. Cancer Res 1984;44(Suppl): 4721-30.
34. Firusian N. Chemo- and laser therapy of advanced tumors of the upper gastrointestinal tract. Onkologie 1988;11(Suppl 2):23-33.
35. Zenone T, Romestaing P, Lambert R, Gerard JP. Curative non-surgical combined treatment of the oesophagus. Eur J Cancer 1992;28:1380-6.
36. Highley MS, Parnis FX, Trotter GA, et al. Combination chemotherapy with epirubicin, cisplatin and 5-fluorouracil for the palliation of advanced gastric and oesophageal adenocarcinoma. Br J Surg 1994;81:1763-5.
37. Murphree AL, Villablanca JG, Deegan WF, et al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol 1996;114:1348-56.
38. Zanke BW, Boudreau K, Rubie E, et al. The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat. Curr Biol 1996;6(5):606-13.
39. Beketic-Oreskovic L, Jaksic M, Oreskovic S, Osmak M. Hyperthermic modulation of resistance to cis-diamminedichloroplatinum (II) in human larynx carcinoma cells. Int J Hyperthermia 1997;13(2):205-14.
40. Hettinga JV, Lemstra W, Meijer C, et al. Hyperthermic potentiation of cisplatin toxicity in a human small cell lung carcinoma cell line and a cisplatinresistant subline. Int J Hyperthermia 1994;10(6):795-805.
41. Ohno S, Siddik ZH, Kido Y, Zwelling LA, Bull JM. Thermal enhancement of drug uptake and DNA adducts as a possible mechanism for the effect of sequencing hyperthermia on cisplatin-induced cytotoxicity in L1210 cells. Cancer Chemother Pharmacol 1994;34(4):302-6.
42. Rauko P, Novotny L, Balazova E. DNA breakage and inactivation resulting from hydroxylamine and/or cis-diamminedichloroplatinum(II) interactions with plasmid DNA. Int J Biochem 1993;25(10):1475-81.
43. Oldenburg J, Begg AC, van Vugt MJ, et al. Characterization of resistance mechanisms to cis-diamminedichloroplatinum(II) in three sublines of the CC531 colon adenocarcinoma cell line in vitro. Cancer Res 1994;54(2): 487-93.
44. Hettinga JV, Lemstra W, Meijer C, et al. Heat-shock protein expression in cisplatin-sensitive and -resistant human tumor cells. Int J Cancer 1996;67(6):800-7.